Rates of efficacy by geographic area, hours after infusion, and treatment
| Geographic area . | FEIBA, % . | NovoSeven, % . |
|---|---|---|
| Western Europe/North America | ||
| 2 h* | 75.0 | 65.0 |
| 6 h | 73.7 | 79.0 |
| Eastern Europe/Russia | ||
| 2 h* | 75.0 | 57.1 |
| 6 h | 85.7 | 78.6 |
| Geographic area . | FEIBA, % . | NovoSeven, % . |
|---|---|---|
| Western Europe/North America | ||
| 2 h* | 75.0 | 65.0 |
| 6 h | 73.7 | 79.0 |
| Eastern Europe/Russia | ||
| 2 h* | 75.0 | 57.1 |
| 6 h | 85.7 | 78.6 |
Efficacy is defined as effective or partially effective by patient rating. For the Western Europe/North America group, N = 20; for the Eastern Europe/Russia group, N = 28.
Prior to second dose of NovoSeven.